1. Fritz JB: Carnitine and its role in fatty acid metabolism. Adv Lipid Res1:285–334, 1963.
2.
2. Gulewitsch VS, Krimberg R: Zur Kenntris der extraktiostoffe der muskein. 2. Mitteilung-Veber das carnitine. Hoppe-Seyler'sZ Phvsiol Chem45:326–330, 1905.
3.
3. Tomita M, Sendju Y: Über die Oxyaminoverbindungen, welche die Biuret reaktion zeigen. III. Spaltung der γ-Amino-β-oxy-but-tersäure in die optischaktinen Komponenten. Hoppe-Seyler's Z Physiol Chem169:263–278, 1927.
4.
4. Fraenkel G, Friedman S: Carnitine. IN Vitamins and Hormones, vol 15, Harris R, Marrian G, Thimann K (eds). New York, Academic Press, 1957, pp 73–118
5.
5. Fritz IB: Action of carnitine on long chain fatty acid oxidation by liver. Am J Physiol197:297–304, 1959.
6.
6. Fritz IB, Kaplan E, Yu KTN: Specificity of carnitine actions on fatty acid oxidation by heart muscle. Am J Physiol202:117–121, 1962.
7.
7. Bohmer T, Rydning A, Solberg HE: Carnitine levels in human serum in health and disease. Clin Chim Acta57:55–61, 1974.
8.
8. DiMauro S, Rowland L: Urinary excretion of carnitine in Duchenne muscular dystrophy. Arch Neurol33:204–295, 1976.
10. Maebashi M, Kawamura N, Sato M, et al: Urinary excretion of carnitine in patients with hyperthyroidism and hypothyroidism: augmentation by thyroid hormone. Metabolism26:351–361, 1977.
11.
11. Boudin G, Mikol J, Guillard A, et al: Fatal systemic carnitine deficiency with lipid storage in skeletal muscle, heart, liver and kidney. J Neurol Sci30:313–325, 1976.
12.
12. Rudman D, Sewell EW, Ansley JD: Deficiency of carnitine in cachectic cirrhotic patients. J Clin Invest60:716–723, 1977.
13.
13. Bohmer T, Bergrem H, Eiklid K: Carnitine deficiency induced during intermittent haemodialysis for renal failure. Lancet1:126–129, 1978.
14.
14. Pande SV, Blanchaer MC: Preferential loss of ATP-dependent long chain fatty acid activating enzyme in mitochondria prepared using Nagarse. Biochim Biophys Acta202:43–48, 1970.
15.
15. Kornberg A, Pricer WE Jr: Enzymatic synthesis of the coenzyme A derivatives of long chain fatty acids. J Biol Chem204:329–343, 1953.
16.
16. Brosman JT, Fritz IB: The permeability of mitochondria to carnitine and acyl carnitine. Biochem J125:94, 1971.
17.
17. Fritz IB: A hypothesis concerning the role of carnitine in the control of interrelationships between fatty acids and carbohydrate metabolism. Perspect Biol Med10:643–677, 1967.
18.
18. Fritz IB, McEwen B: Effects of carnitine on fatty acid oxidation by muscle. Science129:334–335, 1959.
19.
19. Fritz IB, Schultz SK, Srere PA: Properties of partially purified carnitine acetyl transferase. J Biol Chem238: 2509–2517, 1963.
20.
20. Fritz IB, Yu KTN: Long chain carnitine acyl transferase and the role of acylcarnitine derivatives in the catalytic increase of long chain fatty acid oxidation. J Lipid Res4:279–288, 1963.
21.
21. Hoppel CL, Tomec RJ: Carnitine palmityl transferase. Location of two enzymatic activities in rat liver mitochondria. J Biol Chem247:832–841, 1972.
22.
22. Kopec B, Fritz IB: Properties of a purified carnitine palmitoyltransferase and evidence of other carnitine acyltransferases. Can J Biochem49:941–948, 1971.
23.
23. Kopec B, Fritz IB: Comparison of properties of carnitine palmitoyltransferase I with those of carnitine palmitoyltransferases. J Biol Chem248:4069–4074, 1973.
25. Haddock BA, Yates DW, Garland PB: The localization of some coenzyme A dependent enzymes in rat liver mitochondria. Biochem J119:565–573, 1970.
26.
26. Lumeng L, Bremer J, Davis E: Suppression of mitochondrial oxidation of (-)-palmitylcarnitine by the malate-aspartate and L-glycerophosphate shuttles. J Biol Chem251:277–284, 1976.
27.
27. Oram JF, Wenger JL, Neely JR: Regulation of long chain fatty acid activation in heart muscle. J Biol Chem256:73–78, 1975.
28.
28. Oram JF, Bennetch SL, Neely JR: Regulation of fatty acid utilization in isolated perfused rat hearts. J Biol Chem248: 5299–5309, 1973.
29.
29. Hochachka PW, Neely JR, Driedzie WR: Integration of lipid utilization with Krebs cycle activity in muscle. Fed Proc36:2009–2014, 1977.
30.
30. Bremer J: Carnitine in intermediary metabolism. Reversible acetylation of carnitine by mitochondria. J Biol Chem237: 2228–2231, 1962.
31.
31. Fritz IB, Yue KTN: Effects of carnitine on acetyl-CoA oxidation by heart muscle mitochondria. Am J Physiol206:531–535, 1964.
32.
32. Chase JFA: The substrate specificity of carnitine acetyltransferase. Biochem J104:510–518, 1967.
33.
33. Pande SV: On rate-controlling factors of long chain fatty acid oxidation. J Biol Chem246: 5384–5390, 1971.
34.
34a. Lindstedt S, Lindstedt G: Distribution and excretion of carnitine in the rat. Acta Chim Scand15:701–702, 1961.
35.
35. Marquis NR, Fritz IB: Enzymological determination of free carnitine concentrations in rat tissues. J Lipid Res5:184–187, 1964.
36.
36. Cederblad G, Lindstedt S: A method for the determination of carnitine in picomole range. Clin Chim Acta37:235–243, 1972.
37.
37. McGarry JP, Foster DW: An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. J Lipid Res17:277–281, 1976.
38.
38. Pace JA, Wannemacher RW Jr, Newfeld HA: Improved radiochemical assay for carnitine and its derivatives in plasma and tissue extracts. Clin Chem24:32–35, 1978.
39.
39. Linneweh W: γ-Butyrobetain, crotonbetain und carnitine un tier-ischen stoffwechsel. Hoppe-Seyler'sZ Physiol Chem181:42–53, 1929.
40.
40. Lindstedt GT, Lindstedt S: On the biosynthesis and degradation of carnitine. Biochem Biophys Res Commun6:319–323, 1961.
41.
41. Lindstedt G, Lindstedt S: On the hydroxylation of gamma-buty-robetaine to carnitine in vitro. Biochem Biophys Res Commun7: 394–397, 1962.
42.
42. Lindstedt G: Hydroxylation of γ-butyrobetaine to carnitine in rat liver. Biochemistry6: 1271–1282, 1967.
43.
43. Wolf G, Berger CRA: Studies on the biosynthesis and turnover of carnitine. Arch Biochem Biophys92:360–365, 1961.
44.
44. Khairallah EA, Wolf G: Growth-promoting and lipotropic-effect of carnitine in rats fed diets limited in protein and methionine. J Nutr87:469–476, 1967.
45.
45. Strength DR, Yu SY: Origin of the methyl groups of carnitine. Fed Proc21:1158, 1962 (Abstr)
46.
46. Tanphaichitr V, Broquist HP: Lysine deficiency in the rat: concomitant impairment in carnitine biosynthesis. J Nutr103:80–87, 1973.
47.
47. Tanphaichitr V, Broquist HP: Site of carnitine biosynthesis in the rat. J Nutr104:1669–1673, 1974.
48.
48. Khan L, Bamji M: Tissue carnitine deficiency due to dietary lysine deficiency: triglyceride accumulation and concomitant impairment in fatty acid oxidation. J Nutr109:24–31, 1979.
49.
49. Borum PR, Broquist HP: Lysine deficiency and carnitine in male and female rats. J Nutr107: 1209–1215, 1977.
50.
50. Broquist HP, Home DW, Tanphaichitr V: Lysine metabolism in protein-calorie malnutrition with attention to the synthesis of carnitine. IN Protein-Calorie Malnutrition. Olsen RE (ed). New York, Academic Press, 1975, pp 49–60.
51.
51. Haigler HT, Broquist HP: Carnitine synthesis in rat tissue slices. Biochem Biophys Res Commun56:676–681, 1974.
52.
52. Paik WK, Kim S: Protein methylation: chemical, enzymological and biological significance. Adv Enzymol42:227–286, 1975.
53.
53. Cox RA, Hoppel CL: Biosynthesis of carnitine and 4-iV-trimeth-ylaminobutyrate from 6-iV-trimethyllysine. Biochem J136:1038–1090, 1973.
54.
54. Tanphaichitr V, Broquist HP: Role of lysine and iV-trimethyl-lysine in carnitine biosynthesis. II. Studies in rats. J Biol Chem248:2176–2181, 1973.
55.
55. LaBadie J, Dunn WA, Aronson NN Jr: Hepatic synthesis of carnitine from protein-bound trimethyl-lysine. Lysosomal digestion of methyl-lysine-labelled asialo-fetuin. Biochem J160:85–95, 1976.
56.
56. Hulse, JD, Ellis SR, Henderson LM: Carnitine biosynthesis. β-Hydroxylation of trimethyllysine by an α-ketoglutarate-dependent mitochondrial deoxygenase. J Biol Chem253:1654–1659, 1978.
57.
57. Hochalter JB, Henderson LM: Carnitine biosynthesis: the formation of glycine from carbons 1 and 2 of 6-N-trimethyl-L-lysine. Biochem Biophys Res Commun70:364–366, 1976.
58.
58. Mitchell ME: Carnitine metabolism in human subjects. I. Normal metabolism. Am J Clin Nutr31:293–306, 1978.
59.
59. Mikhail M, Mansour M: The relationship between serum carnitine levels and the nutritional status of patients with schistosomiasis. Clin Chim Acta71:207–214, 1976.
60.
60. Karpati G, Carpenter S, Engel A, et al: The syndrome of systemic carnitine deficiency. Neurology25:16–24, 1975.
61.
61. Angelini C, Lucke S, Cantarutti F: Carnitine deficiency of skeletal muscle: report of a treated case. Neurology26:633–637, 1976.
62.
62. Gillies PJ, Bell FP: Arterial and plasma carnitine levels in rabbits: influence of age and dietary cholesterol. Exp Mol Pathol25:402–411, 1976.
63.
63. Bohmer T, Rydning A, Solberg HE: Carnitine levels in human serum in health and disease. Clin Chim Acta57:55–61, 1974.
64.
64. Brooks H, Goldberg L, Holland R, et al: Carnitine-induced effects on cardiac and peripheral hemodynamics. J Clin Pharmacol17: 561–568, 1977.
65.
65. Christiansen R, Bremer J: Active transport of butyrobetaine and carnitine into isolated liver cells. Biochim Biophys Acta448:562–577, 1977.
66.
66. Pearson DJ, Tubbs PK: Carnitine and derivatives in rat tissue. Biochem J105:953–963, 1967.
67.
67. Bohmer T, Kaare R, Bremer J: The relative amounts of long-chain acylcarnitine, acetylcarnitine and free carnitine in organs of rats in different nutritional states and alloxan diabetes. Biochim Biophys Acta125:244–251, 1966.
68.
68. Bohmer T: Tissue levels of activated fatty acids (acyl carnitine) and the regulation of fatty acid metabolism. Biochim Biophys Acta144:259–270, 1967.
69.
69. Choi TR, Fogle PJ, Bieber LL: The effect of long-term fasting on the branched chain acylcarnitines and branched chain carnitine acyltransferases. J Nutr109:155–161, 1979.
70.
70. Corredor C, Mansbash C, Bressler R: Carnitine depletion in the choline deficient state. Biochim Biophys Acta144:366–374, 1967.
71.
71. Carter AL, Frenkel R: The relationship of choline and carnitine in the choline deficient rat. J Nutr108:1748–1754, 1978.
72.
72. Delisle G, Radomski MW: The role of carnitine in the animal exposed to cold. Can J Physiol Pharmacol,46:71–75, 1968.
73.
73. Borum PR: Variation in tissue carnitine concentrations with age and sex in the rat. Biochem J176:677–681, 1978.
74.
74. Therriault DG, Mehlman MA: Metabolism of carnitine in cold-acclimated rats. Can J Biochem43:1437–1443, 1967.
75.
75. Van Alstyne EL, Sladek CD, Smith DC: The effect of thermal injury on plasma carnitine in rats. ExperientiaA33. 863–864, 1977.
76.
76. Mitchell ME: Carnitine metabolism in human subjects. II. Values of carnitine in biological fluids and tissues of “normal” subjects. Am J Clin Nutr31:481–491, 1978.
77.
77. Cederblad G: Plasma carnitine and body composition. Clin Chim Acta67:207–212, 1976.
78.
78. Cederblad G, Lindstedt S, Lundholm K: Concentration of carnitine in human muscle tissue. Clin Chim Acta53:311–321, 1974.
79.
79. Cederblad G, Bylund A, Holm J, et al: Carnitine concentration in relation to enzyme activities and substrate utilization in human skeletal muscles. Scand J Clin Lab Invest36:547–552, 1976.
80.
80. DiMauro S, Scott C, Penn AS, et al: Serum carnitine: an index of muscle destruction in man. Arch Neurol28:186–190, 1973.
81.
81. Rebouche CJ: Carnitine movement across muscle cell membranes. Studies in isolated rat muscle. Biochim Biophys Acta471:145–155, 1977.
82.
82. Willner JH, Ginsburg S, DiMauro S: Active transport of carnitine into skeletal muscle. Neurology28:721–724, 1978.
83.
83. Molstad P, Bohmer T, Eiklid K: Specificity and characteristics of the carnitine transport in human heart cells (CCL 27) in culture. Biochim Biophys Acta471:296–364, 1977.
84.
84. Tsai AC, Romsos DR, Leveille GA: Significance of dietary carnitine for growth and carnitine turnover in rats. J Nutr104:782–792, 1974.
85.
85. Tsai AC, Romsos DR, Leveille GA: Determination of carnitine turnover in choline-deficient and cold-exposed rats. J Nutr105: 301–307, 1975.
86.
86. Mehlman MA, Abdel-Kader MM, Therriault DG: Metabolism, turnover time, half-life, body pool of carnitine-14C in normal, alloxan diabetic and insulin treated rats. Life Sci8:465–472, 1969.
87.
87. Mehlman MA, Therriault DG, Tobin BB: Carnitine 14C metabolism in choline-deficient, alloxan-diabetic choline-deficient and insulin-treated rats. Metabolism20:100–107, 1971.
88.
88. Khairallah EA, Mehlman MA: The turnover, body pool and daily excretion of carnitine as determined by isotope-dilution techniques. IN Recent Research on Carnitine. Its Relation to Lipid Metabolism. Wolf G (ed). Cambridge, Mass., MIT Press, 1967, pp 57–62.
89.
89. Brooks DE, Mcintosh JE: Turnover of carnitine by rat tissues. Biochem J148:439–445, 1975.
91. Cederblad G, Lindstedt S: Excretion of L-carnitine in man. Clin Chim Acta33:117–123, 1971.
92.
92. Maebashi M, Kawamura N, Yoshinaga K: Urinary excretion of carnitine in progressive muscular dystrophy. Nature249:173–174, 1974.
93.
93. Maebashi M, Kawamura N, Yoshinaga K, et al: Urinary excretion of carnitine in man. J Lab Clin Med87:760–766, 1976.
94.
94. Suzuki M, Kanaya M, Muramatsu S, et al: Effects of carnitine administration, fasting and exercise on urinary carnitine excretion in man. J Nutr Sci Vitaminol22:169–174, 1976.
95.
95. Seim H, Strack E: Acetylcarnitine in the blood and urine of the mouse after injection of L-carnitine and several O-acyl-L-carni-tines. Hoppe-Seyler'sZ Physiol Chem358:675–683, 1977.
96.
96. Folts JD, Shug AL, Kobe JR, et al: Protection of the ischemic dog myocardium by L-carnitine. Am J Cardiol41:1209–1214, 1978.
97.
97. Thomsen JH, Shug AL, Yap VU, et al: Improved pacing tolerance of the ischemic human myocardium after administration of carnitine. Am J Cardiol43:300–306, 1979.
98.
98. Tanphaichitr V, Zaklama MS, Broquist HP: Dietary lysine and carnitine: relation to growth and fatty livers in rats. J Nutr1106: 111–117, 1976.
99.
99. Harper AE, Winje ME, Benton DA, et al: Effect of amino acid supplements on growth and fat deposition in the livers of rats fed polished rice. J Nutr56:187–198, 1955.
100.
100. Bressler R: Fatty acid oxidation. IN Comprehensive Biochemistry. Lipid Metabolism, vol 18, Flockin M, Stotz EH (eds). New York, Elsevier, 1970, p 331
101.
101. Robler-Valdes C, McGarry JD, Foster DW: Maternal-fetal carnitine relationships and neonatal ketosis in the rat. J Biol Chem251: 6007–6012, 1976.
102.
102. McGarry JD, Weight PH, Foster DW: Hormonal control of keto-genesis. Rapid activation of hepatic ketogenic capacity in fed rats by anti-insulin serum and glucogen. J Clin Invest55:1202–1209, 1975.
103.
103. Hulsmann WC, Siliprandi D, Ciman M, et al: Effect of carnitine on the oxidation of alpha-oxoglutarate to succinate in the presence of acetoacetate or pyruvate. Biochim Biophys Acta93:166–168, 1964.
104.
104. Broekhuysen J, Baudine A, Deltour G: Effect of carnitine on acidosis and ketosis induced by lipid perfusions in dogs during starvation. Biochim Biophys Acta106:207–210, 1965.
105.
105. Soling AD, Apples A: Effects of L-carnitine on utilization of ketone bodies and glucose in eviscerated nephrectomized rats. Biochim Biophys Acta158:162–164, 1968.
106.
106. Gravina E, Gravina-Sanvitale G: Effect of carnitine on blood acetoacetate in fasting children. Clin Chim Acta23:376–377, 1969.
107.
107. Yeh YY: Carnitine stimulates the utilization of ketone bodies in suckling and adult rats in vivo. Biochem J, 1979 (submitted for publication)
108.
108. McGarry JD, Robles-Valdes C, Foster DW: Role of carnitine in hepatic ketogenesis. Proc Natl Acad Sci USA72:4385–4388, 1975 .
109.
109. Opie LH: Metabolism of the heart. I. Metabolism of glucose, glycogen, free fatty acids and ketones. Am Heart J76:685–690, 1968.
110.
110. Neely JR, Morgan HE: Relationship between carbohydrate and lipid metabolism and the energy balance of the heart muscle. Ann Rev Physiol36:413–459, 1974.
111.
111. Oliver MF, Kurien VA, Greenwood TW: Relation between serum free fatty acids and arrhythmias and death after acute myocardial infarction. Lancet1:710–715, 1968.
112.
112. Opie LH: Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Am J Cardiol36:938–953, 1975.
113.
113. Opie LH: Role of carnitine in fatty acid metabolism of normal and ischemic myocardium. Am Heart J97:375–388, 1979.
114.
114. Shug AL, Thomsen JH, Folts JD, et al: Changes in tissue levels of carnitine and other metabolites during myocardial ischemia and anoxia. Arch Biochem Biophys187:25–33, 1978.
115.
115. Shug AL, Shrago E, Bittar N, et al: Acyl-CoA inhibition of adenine nucleotide translocation in ischemic myocardium. Am J Physiol228:689–692, 1975.
116.
116. Pande SV, Blanchaer MC: Reversible inhibition of mitochondrial adenosine diphosphate phosphorylation by long chain acyl-CoA esters. J Biol Chem246:402–411, 1971.
117.
117. Fanelli O: Carnitine and acetyl-carnitine, natural substance endowed with interesting pharmacological properties. Life Sci23: 2563–2570, 1978.
118.
118. Bartel L, Hussey J, Shrago E: Serum and tissue carnitine in the rat during peritoneal dialysis. Fed Proc38:280, 1979 (Abstr)
119.
119. Fulks RM, Li JB, Goldberg AL: Effects of insulin, glucose and amino acids on protein turnover in rat diaphragm. J Biol Chem250:290–298, 1975.
120.
120. Buse MG, Reid M: Leucine, a possible regulator of protein turnover in muscle. J Clin Invest56: 1250–1261, 1975.
121.
121. Freund H, Yoshimura N, Lunetta C, et al: The role of the branched-chain amino acids in decreasing muscle catabolism in vivo. Surgery83:611–618, 1978.
122.
122. Bieber CL, Choi Y, Sabourin P: Identification of water-soluble acyl-carnitines isolated from heart, muscle, liver and testes. Fed Proc36:652, 1977.
123.
123. Solbert HE, Bremer J: Formation of branched-chain acyl carnitines in mitochondria. Biochim Biophys Acta222:372–380, 1970.
124.
124. Spydevold O, Davis EJ, Bremer J: Replenishment and depletion of citric acid cycle intermediates in skeletal muscle. Eur J Biochem71:155–165, 1976.
125.
125. Choi YR, Fogle PJ, Bieber LL: The effect of long-term fasting on the branched chain acylcarnitine and branched-chain carnitine acyl-transferases. J Nutr169:155–161, 1979.
126.
126. Paul HS, Adibi SA: Effect of carnitine on branched-chain amino acid oxidation by liver and skeletal muscle. Am J Physiol234: E494–E499, 1978.
127.
127. Paul HS, Adibi SA: Mechanism of carnitine stimulation of branched-chain amino acid oxidation. Fed Proc38:355, 1979 (Abstr)
128.
128. Hain P, Skala J, Davies P: Carnitine enhances the effect of norepinephrine on oxygen consumption in rats and mice. Can J Physiol Pharmacol49:853–855, 1971.
129.
129. Mitchell MF: Carnitine metabolism in human subjects. HI. Metabolism in disease. Am J Clin Nutr31:645–659, 1978.
130.
130. Khan L, Bamji MS: Plasma carnitine levels in children with protein-calorie malnutrition before and after rehabilitation. Clin Chim Acta75:163–166, 1977.
131.
131. Cederblad G, Lundholm K, Sebersten T: Carnitine concentration in skeletal muscle tissue from patients with diabetes mellitus. Acta Med Scand202:305–306, 1977.
132.
132. Bardley WG, Hudgson P, Gardner-Medwin D: Myopathy associated with abnormal lipid metabolism in skeletal muscle. Lancet1: 495–498, 1969.
133.
133. Engel AG, Vick NA, Glueck CJ: A skeletal muscle disorder associated with intermittent symptoms and a possible, defect of lipid metabolism. N Engl J Med282:697–704, 1970.
134.
134. Bressler R: Carnitine and the twins, (editorial). N Engl J Med282: 745–746, 1970.
135.
135. Engel AG, Angelini C: Carnitine deficiency of human muscle with associated lipid storage myopathy: a new syndrome. Science179: 899–902, 1973.
137. Vandyke DG, Griggs RC, Markesbery W, et al: Hereditary carnitine deficiency of muscle. Neurology25:154–159, 1975.
138.
138. Issacs H, Heffron JA, Badenhorst M, et al: Weakness associated with the pathological presence of lipid in skeletal muscle: a detailed study of a patient with carnitine deficiency. J Neurol Neu-rosurg Psychiatry39:1114–1123, 1976.
139.
139. Whitaker JN, DiMauro S, Soloman SS, et al: Corticosteroid-responsive skeletal muscle disease associated with partial carnitine deficiency. Studies of liver and metabolic alterations. Am J Med63:805–815, 1977.
140.
140. Engel AG, Banker BQ, Eiben RM: Carnitine deficiency: clinical, morphological, and biochemical observations in a fatal case. J Neurol Neurosurg Psychiatry40:313–322, 1977.
141.
141. Cornelio FD, DiDonato S, Peluchetti D, et al: Fatal cases of lipid storage myopathy with carnitine deficiency. J Neurol Neurosurg Psychiatry40:170–178, 1977.
142.
142. DiDonato S, Cornelio F, Pacini L, et al: Muscle carnitine palmityltransferase deficiency: a case with enzyme deficiency in cultured fibroblast. Ann Neurol4:465–467, 1978.
143.
143. Hostetler KY, Hoppel CL, Romine JS, et al: Partial deficiency of muscle carnitine palmityltransferase with normal ketone production. N Engl J Med298:553–556, 1978.
144.
144. Hart ZH, Chang CH, DiMauro S, et al: Muscle carnitine deficiency and fatal cardiomyopathy. Neurology28:147–151, 1978.
145.
145. Reza MJ, Kar NC, Pearson CM, et al: Recurrent myoglobinuria due to muscle carnitine palmityltransferase deficiency. Ann Intern Med88:610–615, 1978.
146.
146. Schalte HR, Jennebens FGI, Bouvy JJBJ: Carnitine palmitoyltransferase II deficiency with normal carnitine palmitoyltransferase I in skeletal muscle and leukocytes. J Neurol Sci40:39–51, 1979.
147.
147. Engel AG, Sieckert RG: Lipid storage myopathy responsive to prednisone. Arch Neurol27:174–181, 1972.
148.
148. Battistella PA, Angelini C, Vergani I, et al: Carnitine deficiency induced during haemodialysis. Lancet1:939, 1978.
149.
149. Borniche P, Canlorbe P: The clinical and humoral action of carnitine in syndromes of post infectious malnutrition of infancy. Clin Chim Acta5:171–176, 1960.
150.
150. Strack E, Rotzsch W, Lorenz I: Biological action of carnitine in animal bodies. IN Pro tides of the Biological Fluids. Peters H (ed). New York, Elsevier, 1964, p 234
151.
151. Reynier M: Contribution a l'etude theorique et experimentale des propietes biologiques de la carnitine. Rev Agressologic4:361–372, 1963.
152.
152. Maebashi M, Kawamura N, Sato M, et al: Urinary excretion of carnitine and serum concentrations of carnitine and lipids in patients with hypofunctional endocrine diseases: involvement of adrenocorticoid and thyroid hormones in ACTH-induced augmentation of carnitine and lipid metabolism. Metabolism26:357–361, 1971.
153.
153. Maebashi M, Karamura V, Sato M, et al: Lipid-lowering effect of carnitine in patients with Type-IV hyperlipoproteinaemia. Lancet2:805–807, 1978.
154.
154. Schiff D, Chan G, Seccombe D, et al: Plasma carnitine levels during intravenous feeding of the neonate. J Pediatr95:1043–1046, 1979.
155.
155. Border JR, Burns GP, Rumph C, et al: Carnitine levels in severe infection and starvation: a possible key to the prolonged catabolic state. Surgery66:175–179, 1970.
156.
156. Lowry SF, Brennan MF: Abnormal liver function during parenteral nutrition. Relation to infusion excess. J Surg Res26:300–307, 1979.
157.
157. Grant JP, Cox CE, Kleinman LM, et al: Serum hepatic enzyme and bilirubin elevations during parenteral nutrition. Surg Gynecol Obstet145:573–580, 1977.
159. Chinn I, Yoshimura NN, Tao RC, et al: Liver function in growing rats infused with amino acids and/or dextrose. JPEN3:517, 1979 (Abstr)
160.
160. Chang S, Silvas SE: Fatty liver produced by hyperalimentation in rats. Am J Gastroenterol62:410–418, 1974.
161.
161. Buzby GP, Mullen JL, Hansell JR, et al: Relative fat-carbohydrate efficacy in parenteral nutrition support. Surg Forum29:87–89, 1978.
162.
162. Paradis C, Spanier AH, Calder M, et al: Total parenteral nutrition with lipid. Am J Surg135:164–171, 1978.
163.
163. Long JM, Wilmore D-V, Mason AH, et al: Effect of carbohydrate and fat intake on nitrogen excretion during total intravenous feeding. Ann Surg185:417–422, 1977.
164.
164. Greenberg GR, Marliss EB, Anderson GH, et al: Protein-sparing therapy in postoperative patients. N Engl J Med294:1411–1416, 1976.
165.
165. Brennan MF, Fitzpatrick GF, Cohen KH, et al: Glycerol: major contributor to the short term protein sparing affect of fat emulsion in normal man. Ann Surg182:386–394, 1975.
166.
166. Hassov I, Nelsen F, Hang A: Postmortem findings in three patients treated with intravenous fat emulsions. Arch Surg114:66–68, 1979.